{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T20:24:18Z","timestamp":1648844658686},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/s00108-005-1429-2","type":"journal-article","created":{"date-parts":[[2005,5,17]],"date-time":"2005-05-17T15:06:10Z","timestamp":1116342370000},"page":"783-788","source":"Crossref","is-referenced-by-count":0,"title":["60-j\u00e4hriger Patient mit Weichteilinfektion des rechten Beines"],"prefix":"10.1007","volume":"46","author":[{"given":"D.","family":"Hasper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Schrage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.-D.","family":"Schaser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Melcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Barckow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Frei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Oppert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1429_CR1","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1001\/jama.1992.03480240077038","volume":"267","author":"Barry","year":"1992","unstructured":"Barry W, Hudgins L, Donta S, Pesanti E (1992) Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA 267: 3315\u20133316","journal-title":"JAMA"},{"key":"1429_CR2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","volume":"344","author":"Bernard","year":"2001","unstructured":"Bernard GR, Vincent JL, Laterre PF et al.; Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699\u2013709","journal-title":"N Engl J Med"},{"key":"1429_CR3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/376630","volume":"37","author":"Darenberg","year":"2003","unstructured":"Darenberg J, Ihendyane N, Sjolin J et al.; StreptIg Study Group (2003) Intravenous immunglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 37: 333\u2013340","journal-title":"Clin Infect Dis"},{"key":"1429_CR4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0002-9343(52)90293-3","volume":"13","author":"Eagle","year":"1952","unstructured":"Eagle H (1952) Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. Am J Med 13: 389\u2013399","journal-title":"Am J Med"},{"key":"1429_CR5","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1172\/JCI110152","volume":"67","author":"Gemmell","year":"1981","unstructured":"Gemmell CG, Peterson PK, Schmeling D et al. (1981) Potentiation of opsonization and phagocytosis of streptococcus pyogenes following growth in the presence of clindamycin. J Clin Invest 67: 1249\u20131256","journal-title":"J Clin Invest"},{"key":"1429_CR6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9343(97)00160-5","volume":"103","author":"Kaul","year":"1997","unstructured":"Kaul R, McGeer A, Low DE et al. (1997) Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiological analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med 103:18\u201324","journal-title":"Am J Med"},{"key":"1429_CR7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/515199","volume":"28","author":"Kaul","year":"1999","unstructured":"Kaul R, McGeer A, Norrby-Teglund A et al. (1999) Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome \u2014 A comparative observational study. Clin Infect Dis 28: 800\u2013807","journal-title":"Clin Infect Dis"},{"key":"1429_CR8","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1128\/IAI.64.12.5395-5398.1996","volume":"64","author":"Norrby-Teglund","year":"1996","unstructured":"Norrby-Teglund A, Kaul R, Low DE et al. (1996) Evidence for the presence of streptococcal-superantigen-neutralizing antibodies in normal polyspecific immunoglobulin G. Infect Immun 64: 5395\u20135398","journal-title":"Infect Immun"},{"key":"1429_CR9","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1128\/IAI.62.12.5227-5233.1994","volume":"62","author":"Norrby-Teglund","year":"1994","unstructured":"Norrby-Teglund A, Newton D, Kotb M et al. (1994) Superantigenic properties of the group A streptococcal exotoxin SpeF (MF). Infect Immun 62: 5227\u20135233","journal-title":"Infect Immun"},{"key":"1429_CR10","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/infdis\/167.6.1401","volume":"167","author":"Stevens","year":"1993","unstructured":"Stevens DL, Yan S, Bryant AE (1993) Penicillin binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: An explanation for the inoculum effect. J Infect Dis 167: 1401\u20131405","journal-title":"J Infect Dis"},{"key":"1429_CR11","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(94)92548-8","volume":"343","author":"Yong","year":"1994","unstructured":"Yong JM (1994) Necrotising fasciitis. Lancet 343: 1427","journal-title":"Lancet"},{"key":"1429_CR12","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00006454-199912000-00014","volume":"18","author":"Zimbelman","year":"1999","unstructured":"Zimbelman J, Palmer A, Todd J (1999) Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J 18: 1096\u20131100","journal-title":"Pediatr Infect Dis J"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-005-1429-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-005-1429-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-005-1429-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T10:38:15Z","timestamp":1586255895000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-005-1429-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["1429"],"URL":"https:\/\/doi.org\/10.1007\/s00108-005-1429-2","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}